The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

Guillain-Barré Syndrome GBS is a rare neurological disorder where the immune system attacks peripheral nerves leading to weakness numbness and possible paralysis Learn about its causes symptoms treatm ...

Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...

A global research collaboration has revealed how certain gut cells switch on pain signals, which can linger long after the ...

Moderna Inc . (BMV:MRNA) reported its fourth-quarter earnings for 2024, revealing a significant decline in revenue and a net loss. The company's earnings per share (EPS) were lower than expected, and ...

This review summarises the clinical approach to diagnosis and treatment of Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating ... trials and systematic reviews as a basis for management ...